Vitiligo at injection site of PEG-IFN-α 2a in two patients with chronic hepatitis C: Case report and literature review

Case Reports in Dermatology

Volumn 2, Issue 2, 2010, Pages 156-164

  Arya, V ^a   Bansal, M ^a   Girard, L ^a   Arya, S ^a   Valluri, A ^a  

^a WYCKOFF HEIGHTS MEDICAL CENTER   (United States)

Author keywords

Chronic hepatitis C; Injection site; PEG IFN 2a; Vitiligo

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CHRONIC DISEASE; DEPIGMENTATION; DRUG INDUCED DISEASE; FEMALE; HEPATITIS C; HUMAN; INJECTION SITE; INJECTION SITE REACTION; INJECTION SITE VITILIGO; MALE; MELANOCYTE; PIGMENT DISORDER; PRIORITY JOURNAL; TREATMENT DURATION; VIRUS TYPING; VITILIGO;

EID: 79951971245     PISSN: None     EISSN: 16626567     Source Type: Journal    
DOI: 10.1159/000320207     Document Type: Article

References (43)

1. Wieckowska A, McCullough AJ, Feldstein AE: Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 2007;46:582-589. (Pubitemid 47344794)
2. Russo MW, Fried MW: Side effects of therapy for chronic hepatitis C. Gastroenterology 2003;124:1711-1719. (Pubitemid 36617688)
3. Seckin D, Durusoy C, Sahin S: Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection. Pediatr Dermatol 2004;21:577-579. (Pubitemid 39363180)
4. Guillot B, Blazquez L, Bessis D, Dereure O, Guilhou JJ: A prospective study of cutaneous adverse events induced by low-dose alpha Interferon treatment for malignant melanoma. Dermatology 2004;208:49-54. (Pubitemid 38142334)
5. Simsek H, Savas C, Akkiz H, Telatar H: Interferon-induced vitiligo in a patient with chronic viral hepatitis C infection. Dermatology 1996;193:65-66. (Pubitemid 26257102)
6. Bernstein D, Reddy KR, Jeffers L, Schiff E: Canities and vitiligo complicating interferon therapy for hepatitis C. Am J Gastroenterol 1995;90:1176-1177.
7. Patricia T, Hadi S, Al-Ghaithi K, Al-Qari H, Rudikoff D: Segmental vitiligo and hair curling after interferon alpha and ribavirin treatment for hepatitis C. Skinmed 2006;5:50-51.
8. Anbar TS, Abdel-Rahman AT, Ahmad HM: Vitiligo occurring at site of interferon-alpha 2b injection in a patient with chronic viral hepatitis C: a case report. Clin Exp Dermatol 2008;33:503. (Pubitemid 351832139)
9. Gilhar A, Zelickson B, Ulman Y, et al: In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo. J Invest Dermatol 1995;105:683-686.
10. Van den Wijngaard R, Wankowicz-Kalinska A, Le Poole IC, Tigges B, Westerhof W, Das PK: Local immune response in skin of generalized vitiligo patients: destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 2000;80:1299-1309. (Pubitemid 30637070)
11. Rossi G, Tucci A, Cariani E, Ravaggi A, Rossini A, Radaeli E: Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: different prognosis according to the immune status. Blood 1997;90:1309-1314. (Pubitemid 27314170)
12. Fan XG, Liu WE, Li CZ, Wang ZC, Luo LX, Tan DM, Hu GL, Zhang Z: Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection. Mediators Inflamm 1998;7:295-297. (Pubitemid 28419525)
13. El-Serag HB, Hampel H, Yeh C, Rabeneck L: Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002;36:1439-1445. (Pubitemid 35403535)
14. Jadali Z, Eslami MB, Sanati MH, Mansouri P, Mahmoudi M, Maghsoudi N, et al: Hepatitis C virus antibodies and vitiligo disease. Iranian J Publ Health 2005;34:23-26. (Pubitemid 41358359)
15. Akbayir N, Gökdemir G, Mansur T, Sökmen M, Gündüz S, Alkim C, et al: Is there any relationship between hepatitis C virus and vitiligo? J Clin Gastroenterol 2004;38:815-817.
16. Hamadah I, Binamer Y, Sanai FM, Abdo AA, Alajlan A: Interferon-induced vitiligo in hepatitis C patients: a case series. Int J Dermatol 2010;49:829-833.
17. Krzysztof T, Romana M, Grażyna S: Vitiligo associated with pegylated interferon and ribavirin treatment of patients with chronic hepatitis C: a case report. Adv Ther 2006;23:139-142.
18. Taffaro M, Pyrsopoulos N, Cedron H, Cacayorin E, Weppler D, Moon J, et al: Vitiligo improvement in a hepatitis C patient after treatment with PEG-interferon alpha-2a and ribavirin: a case report. Dig Dis Sci 2007;52:3435-3437. (Pubitemid 350077181)
19. Blaheta RA, Scholz M, Hailer NP, Bereiter-Hahn J, Encke A, Markus BH: Adhesion and penetration properties of human lymphocytes acting on allogeneic vascular endothelial cells. Immunology 1994;81:538-545. (Pubitemid 24246501)
20. Ronnblom LE, Alm GV, Oberg K: Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment. Acta Oncol 1991;30:537-540.
21. Robert R, Fleisher T, Shearer W, Schroeder H, Frew A, Weyand C: Fundamental Principles of the Immune Response. Clinical Immunology Principles and Practice, 3rd ed. Elsevier, 2008, pp 3-26.
22. Gowda S, Tillman DK, Fitzpatrick JE, Gaspari AA, Goldenberg G: Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma. J Cutan Pathol 2009;36:878-881.
23. Sriprakash K, Godbolt A: Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma. Australas J Dermatol 2009;50:211-213.
24. Cerchione C, Fabbricini R, Pane F, Luciano L: Vitiligo-like lesions in an adult patient treated with imatinib mesylate. Leuk Res 2009;33:e104-e105.
25. Curzytek K, Pietowska J, Spiewak R: Vitiligo induced by drugs: a meta-analysis of reported cases. Allergy 2007;62(suppl 83:XXVI Congress of the European Academy of Allergology and Clinical Immunology):447.
26. Kovacs SO: Vitiligo. J Am Acad Dermatol 1998;38:647-666.
27. Schwartz RA, Janniger CK: Vitiligo. Cutis 1997;60:239-244. (Pubitemid 127473333)
28. MacKie RM: Vitiligo; in: Clinical Dermatology, 5th ed. Oxford University Press, New York, 2003, pp 227-229.
29. Svitra PP, Perry H: Vogt-Koyanagi-Harada (uveomeningitic) syndrome; in Albert DA, Jakobiec FA (eds): Principles and Practice of Ophthalmology: Clinical Practice v1. WB Saunders, Philadelphia, 1994, chapter 31.
30. Choudhuri G, Somani SK, Baba CS, Alexander G: Autoimmune hepatitis in India: profile of an uncommon disease. BMC Gastroenterol 2005;5:27.
31. Sarin SK, Monga R, Sandhu BS, Sharma BC, Sakhuja P, Malhotra V: Primary biliary cirrhosis in India. Hepatobiliary Pancreat Dis Int 2006;5:105-109.
32. Collin P, Reunala T: Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologist. Am J Clin Dermatol 2003;4:13-20. (Pubitemid 36078536)
33. Amerio P, Di Rollo D, Carbone A, Auriemma M, Marra ME, De Remigis P, Feliciani C, Tracanna M, Tulli A: Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases. Eur J Dermatol 2010;20:354-358.
34. Tanioka M, Yamamoto Y, Katoh M, Takahashi K, Miyachi Y: Vitiligo vulgaris and autoimmune diseases in Japan: a report from vitiligo clinic in Kyoto University Hospital. Dermatoendocrinol 2009;1:43-45.
35. Borlu M, Cölgeçen E, Evereklioglu C: Behçet's disease and vitiligo in two brothers: coincidence or association? Clin Exp Dermatol 2009;34:e653-e655.
36. Silva Dda F, Anunciação FA, Carvalho LL, Budaruiche JS: Vitiligo in a patient with pachydermoperiostosis: a fortuitous association? Acta Reumatol Port 2008;33:364-367.
37. Nanda A: Autoimmune diseases associated with neurofibromatosis type 1. Pediatr Dermatol 2008;25:392-393.
38. Sanli H, Akay BN, Arat M, Koçyigit P, Akan H, Beksac M, Ilhan O: Vitiligo after hematopoietic cell transplantation: six cases and review of the literature. Dermatology 2008;216:349-354. (Pubitemid 351630103)
39. Karabudak O, Dogan B, Yildirim S, Harmanyeri Y, Anadolu-Brasie R: Dermatitis herpetiformis and vitiligo. J Chin Med Assoc 2007;70:504-506. (Pubitemid 350285075)
40. Iacovelli P, Sinagra JL, Vidolin AP, Marenda S, Capitanio B, Leone G, Picardo M: Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology 2005;210:26-30. (Pubitemid 39656715)
41. Kemp EH, Waterman EA, Weetman AP: Autoimmune aspects of vitiligo. Autoimmunity 2001;34:65-77. (Pubitemid 32888276)
42. Grimes PE: White patches and bruised souls: advances in the pathogenesis and treatment of vitiligo. J Am Acad Dermatol 2004;51:S5-S7.
43. Nouri K, Busso M, Machler BC: Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C. Cutis 1997;60:289-290. (Pubitemid 127469616)